---
schema_version: "secwatch.filing_event.v1"
accession: "0001753926-24-000721"
form_type: "8-K"
ticker: "LIPO"
cik: "0001347242"
company_name: "LIPELLA PHARMACEUTICALS INC."
filed_at: "2024-04-12T23:59:59+00:00"
generated_at: "2026-06-03T23:17:29.233765+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Lipella eliminates Series A Preferred Stock designation after all shares converted to common

## Summary
- Filed Series A Elimination Certificate with Delaware Secretary of State on April 11, 2024.
- All previously issued Series A Preferred Stock converted into common stock; no shares outstanding.
- No further shares will be issued under the Series A designation.
- Certificate became effective immediately upon filing.

## SEC filing metadata
- accession: 0001753926-24-000721
- form_type: 8-K
- ticker: LIPO
- cik: 0001347242
- company_name: LIPELLA PHARMACEUTICALS INC.
- filed_at: 2024-04-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1347242/000175392624000721/0001753926-24-000721-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1347242/000175392624000721/g084176_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001753926-24-000721
- JSON: https://secwatch.observer/filing/0001753926-24-000721.json
- Plain text: https://secwatch.observer/filing/0001753926-24-000721.txt

## Key facts
- Governance Changes
  LIPELLA PHARMACEUTICALS INC.: Eliminated and canceled all designations, rights, preferences and limitations of Series A Preferred Stock (effective 2024-04-11).
  - Change: charter amendment
  - Effective: 2024-04-11
  source text: On April 11, 2024, the Company filed an Elimination of Certificate of Designation of the Preferences, Rights and Limitations of Series A Preferred Stock (the “Series A Elimination Certificate”) with the Secretary of State of the State of Delaware, in order to eliminate and cancel all designations, rights, preferences and limitations of the shares of the Company’s Series A convertible preferred stock, par value $0.0001 per share (the “Series A Preferred Stock”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1347242/000175392624000721/0001753926-24-000721-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.